Acquisition - June 1, 2023
Getinge to acquire High Purity New England
Getinge has announced an agreement to acquire 100% of the shares in High Purity New England, a US-based company in the areas of custom single-use solutions for bioprocessing applications. “This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment,” says Eric Honroth, President Life Science […]
Acquisition - May 10, 2023
Sobi to acquire CTI BioPharma for 1.7 billion USD
Swedish Orphan Biovitrum (Sobi) has entered into an agreement and plan of merger with CTI BioPharma (CTI) under which Sobi has agreed to acquire CTI, by means of a tender offer. Sobi is to commence a cash tender offer to acquire all issued and outstanding shares of CTI for USD 9.10 per share, corresponding to […]
Acquisition - March 29, 2023
Navamedic submits offer to acquire Sensidose
The Norwegian company has submitted a cash offer to acquire all shares in Swedish Sensidose for approximately 75 million SEK. The offer is recommended by the independent bid committee of Sensidose. The Sensidose shares are currently listed on Spotlight Stock Market in Sweden. “This potential transaction is an excellent example of Navamedic’s proactive approach to […]
Acquisition - March 27, 2023
Pharm Assist is now part of LINK Medical
LINK Medical has announced the integration of Pharm Assist into the LINK Medical family. “We are very excited to have Pharm Assist integrate with our network of expert teams, especially strengthening our already robust regulatory group making us very unique in our industry. Our Regulatory team across the Nordics now has over 60 specialists, including […]
Acquisition - March 15, 2023
Pfizer to acquire Seagen
Pfizer and Seagen have entered into a definitive merger agreement under which Pfizer will acquire Seagen for 229 USD in cash per Seagen share for a total enterprise value of 43 billion USD. “Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the […]
Acquisition - February 15, 2023
Biotage acquires Astrea Bioseparations
Biotage has entered into an agreement to acquire Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences. The enterprise value for Astrea is approximately 190 million USD, subject to any closing adjustments and potential milestone-based payments, states the company in a press release. “The acquisition represents an excellent strategic fit for Biotage, and it […]
